<img src="/media/headshots/k/Ken-Kaitin.jpg" width="80" height="80" style="float: left; padding-right: 15px" />The NGP Summit is proud to announce that Kenneth Kaitin – the Director of the Tufts Center for the Study of Drug Development and Professor at Tufts University School of Medicine – will be leading a workshop at the upcoming NGP Summit. The session is titled Mapping the Adoption of Centralized Cardiac Safety Assessment and will highlight the results of the CSDD's industry-wide study to measure current and anticipated adoption levels of centralized ECG. The complete workshop synopsis can be viewed by clicking on the "program" tab on the homepage.
In addition to Dr. Kaitin's presentation, ERT – the industry leader in cardiac safety drug research – will be attending the Summit as a key Solution Provider. ERT has provided unparalleled scientific and regulatory leadership to biopharmaceutical, Contract Research Organizations (CROs) and medical device companies – around the globe. More information on ERT can be found by visiting: www.ert.com.
"This meeting provided an excellent opportunity to meet key thinkers in the clinical study Pharma space and to present the contributions of our technology to them."
Scott Watson, Aperio